GLP-1 Newsroom is your go-to source for breaking news, expert updates, trends, products, and real-world insights on everything related to GLP-1 medications, journeys, and diets.
It turns out, sleep apnea is one of the many benefits science is exploring for GLP-1 agonists. While Zepbound got the first nod for OSA, there's a world of sleep standing between you and taking GLP-1s.
Tirzepatide is one of the newest GLP-1-based medications to get FDA approval, and it’s changing the conversation around weight loss and metabolic health in a big way. While tirzepatide for weight loss is a big lure, it's also used to treat Type 2 Diabetes and Obstructive Sleep Apnea (OSA).
